These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33583015)

  • 1. Atezolizumab-induced pure red cell aplasia.
    Bennett R; Ruskova A
    Br J Haematol; 2021 Apr; 193(1):10. PubMed ID: 33583015
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia.
    Berger M; Amini-Adlé M; Crumbach L; Paubelle E; Dalle S
    Eur J Cancer; 2019 Mar; 110():49-52. PubMed ID: 30739840
    [No Abstract]   [Full Text] [Related]  

  • 3. Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
    Hirai T; Inomata M; Minatoyama S; Hashizume M; Takata N; Hayashi K; Seto Z; Tokui K; Taka C; Okazawa S; Kambara K; Imanishi S; Miwa T; Hayashi R; Tanaka S; Noguchi A; Sato T
    In Vivo; 2024; 38(3):1509-1511. PubMed ID: 38688637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia.
    Berger M; Amini-Adlé M; Crumbach L; Paubelle E; Dalle S
    Eur J Cancer; 2019 May; 112():94-97. PubMed ID: 30954716
    [No Abstract]   [Full Text] [Related]  

  • 5. Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin.
    Isoda A; Miyazawa Y; Tahara K; Mihara M; Saito A; Matsumoto M; Sawamura M
    Intern Med; 2020 Aug; 59(16):2041-2045. PubMed ID: 32389947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual Anemias.
    Daughety MM; DeLoughery TG
    Med Clin North Am; 2017 Mar; 101(2):417-429. PubMed ID: 28189179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe anemia in a patient with multiple sclerosis treated with natalizumab.
    Simone AM; Ferraro D; Vitetta F; Marasca R; Bonacorsi G; Pinelli G; Federzoni L; Nichelli PF; Sola P
    Neurology; 2014 Jul; 83(4):374-5. PubMed ID: 24944259
    [No Abstract]   [Full Text] [Related]  

  • 8. Anemia in a psoriatic patient treated with ixekizumab.
    Nieto-Benito LM; Mateos-Mayo A; Romero-Jiménez R; Baniandrés-Rodríguez O
    J Dermatol; 2020 May; 47(5):e209-e210. PubMed ID: 32124479
    [No Abstract]   [Full Text] [Related]  

  • 9. Pembrolizumab in the Treatment of Breast Cancer.
    Pivot X
    N Engl J Med; 2022 Jul; 387(3):273-274. PubMed ID: 35857664
    [No Abstract]   [Full Text] [Related]  

  • 10. Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.
    Gambichler T; Doerler M; Scheel CH
    Lupus; 2021 Mar; 30(3):531-533. PubMed ID: 33407044
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxygen-induced marrow red cell hypoplasia leading to transfusion in sickle painful crisis.
    Lane PK; Embury SH; Toy PT
    Am J Hematol; 1988 Jan; 27(1):67-8. PubMed ID: 3128106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the editor regarding "Immune checkpoint inhibitor-induced pure red cell aplasia: Case series and large-scale pharmacovigilance analysis".
    Xia S; Gong H; Yan M
    Int Immunopharmacol; 2023 Feb; 115():109705. PubMed ID: 36638661
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoniazid-induced pure red cell aplasia.
    Claiborne RA; Dutt AK
    Am Rev Respir Dis; 1985 Jun; 131(6):947-9. PubMed ID: 3923885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell aplasia in children on tacrolimus after liver transplantation.
    Misra S; Moore TB; Ament ME; Busuttil RW; McDiarmid SV
    Transplantation; 1998 Feb; 65(4):575-7. PubMed ID: 9500636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy.
    Shimazu Y; Mizumoto C; Chonabayashi K; Hanyu Y; Kanda J; Takaori-Kondo A
    Ann Hematol; 2023 Aug; 102(8):2291-2292. PubMed ID: 37103614
    [No Abstract]   [Full Text] [Related]  

  • 16. Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients.
    Elimelakh M; Dayton V; Park KS; Gruessner AC; Sutherland D; Howe RB; Reding MT; Eastlund T; van Burik JA; Singleton TP; Gruessner RW; Key NS
    Haematologica; 2007 Aug; 92(8):1029-36. PubMed ID: 17640860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired idiopathic generalized anhidrosis following pembrolizumab treatment.
    Furuta K; Horiguchi A; Nakagawa Y; Kambe N; Kogame T
    Clin Exp Dermatol; 2022 Feb; 47(2):463-465. PubMed ID: 34610167
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review.
    Dupré A; Michot JM; Schoeffler A; Frumholtz L; Baroudjian B; Delyon J; Lebbe C; Lambotte O
    Br J Haematol; 2020 Jun; 189(5):985-992. PubMed ID: 32243578
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma.
    Loriot Y; Sternberg CN; Castellano D; Oosting SF; Dumez H; Huddart R; Vianna K; Alonso Gordoa T; Skoneczna I; Fay AP; Nolè F; Massari F; Brasiuniene B; Maroto P; Fear S; Di Nucci F; de Ducla S; Choy E
    Eur J Cancer; 2020 Oct; 138():202-211. PubMed ID: 32905959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical review of antibody-mediated pure red cell aplasia.
    Vogel S; Rossert J
    Nephrol Nurs J; 2005; 32(1):17-8, 23-6; quiz 27. PubMed ID: 15787081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.